Page 4 - Synapse Life Sciences Consortium

Fusion

Pharmaceuticals:
Capitalizing on
Nuclear Research

Fusion Pharmaceuticals is a precision
radiopharmaceutical drug development
company that emerged out of IP developed
at McMaster Univesrity and the Centre for
Probe Discovery and Commercialization. Its
initial public offering in 2020 raised more
than USD $212 million, the second-largest
ever for a Canadian biotech company. This
followed a $105 million Series B capital
raise, amongst the largest in Canadian
biotech history. It was named Ontario’s Life
Sciences Company of the Year in 2018.
A History of Setting
McMaster and Fusion are now working
together to build a radiopharmaceutical
manufacturing facility at McMaster the Pace for Change
Innovation Park (MIP) to serve a global
market by 2024.
a culture of discovery, research excellence and a
“Hamilton — based largely on McMaster’s commitment to collaboration has laid the foundation
research and innovation — is quickly for Hamilton’s success, anchored by its academic
becoming one of Ontario’s largest life institutions and research hospitals.
sciences clusters, and we need to ensure
we are prepared to accommodate the mcmaster University is consistently ranked amongst
commercialization activities, and subsequent Canada’s most research-intensive universities,
job creation, of our researchers and local including #1 between 2017-2020, with a total
partners.” said Karen Mossman, Vice sponsored research income of $371.6 million in
President Research at McMaster and chair of 2020. it also ranked no. 2 in medical and science
MIP’s board of directors. grants in the country. the university’s global
reputation included being named among the top
The company formed in 2015 out of the 100 universities in the world since 2003, helping to
research of McMaster professor Dr. John attract leading researchers to the region.
Valliant and the work of the Centre for
Probe Development and Commercialization the university is home to dozens of research centres
(CPDC). Building on McMaster’s decades- and institutes working in human health and life
long leadership in nuclear medicine, sciences.
the CPDC has completed more than 50
radiopharmaceutical discovery, development, Hamilton Health Sciences (HHS) is the 4 ranked
th
and manufacturing programs and brought research hospital in Canada with 10 sites and
more than a dozen products into clinical
development. specialized expertise in cardiovascular, stroke, burns,
neurosurgery, pediatrics, gastrointestinal, high-risk
obstetrics, cancer, orthopedics, and rehabilitation
Valliant, now Fusion’s CEO, says the history- services. it is the most comprehensive hospital
making investment in Fusion will only raise network in ontario, and the only one in the province
awareness about is happening in Hamilton.
that cares for all ages, from gestation to end-of-life.
“We are nimble and fast in Hamilton and St. Joseph’s Healthcare Hamilton has a national
that’s a significant advantage. Hamilton reputation for outstanding patient care and
has great people, research and technology innovative medical and surgical treatments. it is
and is building its ecosystem based on that well known for excellence in respiratory care, kidney
success. This is definitely the time for all this and urinary care, mental health and addictions,
to happen in Hamilton.”
surgical services, cancer surgery, as well as
women’s and infant-care.

4